Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHAR · BSE: 524632 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹69.70
Market cap: ₹3,064 Cr
Revenue (annual): ₹56.73 Cr
Net profit (annual): ₹22.06 Cr
P/E (TTM): 90.2×Sector 47.4×
Promoter holding: 51.15%+0.19% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 3 Board Meeting Outcome 2 SME to Main Board Migration 1 Other Announcement 1 Merger & Restructuring 1 Financial Results 1 Dividend 1 Capital Structure Change 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

14 Aug 2026 15:29 IST BSE

Merger & Restructuring

Shukra Pharmaceuticals Merger & Restructuring

Shukra Pharmaceuticals entered a term sheet for a 60:40 strategic joint venture with Borns Medical Robotics. The venture aims to manufacture AI-enabled surgical robotic systems.

Execution: Approximately 120 days for definitive agreements

Read the filing ↗